Memorial Sloan Kettering radiologist and nuclear medicine physician Rosna Mirtcheva

Rosna Mirtcheva, MD

Radiologist & Nuclear Medicine Physician

Titles

Associate Attending Radiologist

Clinical Expertise

Breast Cancer; Lymphoma; Melanoma; Lung Cancer; Gynecologic Malignancies; Colorectal Cancer; Multiple Myeloma; Positron Emission Tomography/Computed Tomography (PET/CT); General Diagnostic and Therapeutic Nuclear Medicine; General Diagnostic Radiology

Back to top
Share

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, Medical University of Varna

Residencies

Nuclear Medicine - NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Radiology - NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Fellowships

PET/CT - NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Board Certifications

Radiology; Nuclear Medicine

As a dual board-certified diagnostic radiologist and nuclear medicine doctor, I am committed to excellence in oncologic imaging, clinical care, and teaching residents and fellows. I have more than 25 years of experience in the fields of radiology and nuclear medicine, with expertise in molecular oncologic imaging.

Read more

I provide clinical care by interpreting PET/CT scans and a broad variety of conventional nuclear medicine studies that are used for the diagnosis and staging of cancer, as well as to see how treatment has worked. I collaborate closely with medical oncologists, radiation oncologists, and surgeons to provide comprehensive and compassionate care for people with different types of cancer such as breast cancer, lung cancer, and lymphoma.

I trained in both Europe and the United States. My interest in radiology began in medical school. I became fascinated with advanced imaging techniques and their critical role in diagnosing cancer and managing the disease. Later, I was captivated by the molecular approach to imaging and targeted therapies, and molecular oncologic imaging became my main interest. 

I have more than 25 years of experience in the fields of radiology and nuclear medicine, with expertise in molecular oncologic imaging.

-Dr. Mirtcheva

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Molecular Imaging and Therapy Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Rosna Mirtcheva discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: